Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys
F Titti, L Sernicola, A Geraci, G Panzini, S Di Fabio, R Belli, F Monardo, A Borsetti, MT Maggiorella, M Koanga-Mogtomo, F Corrias, R Zamarchi, A Amadori, L Chieco-Bianchi and P Verani Laboratory of Virology, Istituto Superiore di Sanita, Rome, Italy. The ability of a live attenuated simian immunode...
Gespeichert in:
Veröffentlicht in: | Journal of general virology 1997-10, Vol.78 (10), p.2529-2539 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | F Titti, L Sernicola, A Geraci, G Panzini, S Di Fabio, R Belli, F Monardo, A Borsetti, MT Maggiorella, M Koanga-Mogtomo, F Corrias, R Zamarchi, A Amadori, L Chieco-Bianchi and P Verani
Laboratory of Virology, Istituto Superiore di Sanita, Rome, Italy.
The ability of a live attenuated simian immunodeficiency virus (SIV) to
protect against challenge with cloned SIVmac251/BK28 was evaluated in four
cynomolgus macaques. The intravenous infection of the C8 variant of the
SIVmac251/32H virus, carrying an in-frame 12 bp deletion in the nef gene,
did not affect the CD4+ and CD8+ cell counts, and a persistent infection
associated with an extremely low virus burden in peripheral blood
mononuclear cells (PBMCs) was established. After 40 weeks, these monkeys
were challenged intravenously with a 50 MID50 dose of SIVmac251/BK28 virus
grown on macaque cells. Four naive monkeys were infected as controls.
Monkeys were monitored for 62 weeks following challenge. Attempts to rescue
virus from either PBMCs or bone marrow from the C8-vaccinated monkeys were
unsuccessful, but in two cases virus was re-isolated from lymph node cells.
The presence of the SIV provirus with the C8 variant genotype maintaining
its original nef deletion was shown by differential PCR in PBMCs, lymph
nodes and bone marrow. Furthermore, in contrast to the control monkeys, the
vaccinated monkeys showed normal levels for CD4+ and CD8+ cells, minimal
lymphoid hyperplasia and no clinical signs of infection. Our results
confirm that vaccination with live attenuated virus can confer protection.
This appears to be dependent on the ability of the C8 variant to establish
a persistent but attenuated infection which is necessary for inducing an
immune response, as suggested by the persistence of a strong immune B cell
memory and by the over-expression of interleukin (IL)-2, interferon-gamma
and IL-15 mRNAs in PBMCs of C8-vaccinated monkeys but not in those of
control monkeys. |
---|---|
ISSN: | 0022-1317 1465-2099 |
DOI: | 10.1099/0022-1317-78-10-2529 |